Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05100745 · ClinicalTrials.gov registry record · NA
A Non-significant Risk Clinical Study to Assess Perfusion Changes With Application of a TUS for Patients With PAD
A NA study, sponsored by Vibrato Medical.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT05100745: Completed NA study, sponsored by Vibrato Medical.
NCT05100745 is a NA study that has completed, run by Vibrato Medical. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05100745, a NA study, has completed, sponsored by Vibrato Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of the clinical trial is to gather evidence on the safety, performance and clinical efficacy Vibrato Sleeve TUS in people with peripheral artery disease (PAD).
Primary Outcome
Mean difference between pre-treatment (baseline) and/or last sham treatment with post-treatment measurements, including the 2-month follow-up.
Interventions
- DEVICE Therapeutic Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2024-12-11 |
| Phase | NA |
What the finished NCT05100745 record still lists
NCT05100745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Therapeutic Device is the first listed.
NCT05100745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05100745 about?
NCT05100745 is a clinical study titled "A Non-significant Risk Clinical Study to Assess Perfusion Changes With Application of a TUS for Patients With PAD". The objective of the clinical trial is to gather evidence on the safety, performance and clinical efficacy Vibrato Sleeve TUS in people with peripheral artery disease (PAD).
What is the current status of trial NCT05100745?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2023-03-13. Estimated completion is 2024-12-11.
What interventions are being tested in trial NCT05100745?
The interventions under investigation include: Therapeutic Device (DEVICE).
Who is sponsoring clinical trial NCT05100745?
This trial is sponsored by Vibrato Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05100745's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI